Sight Sciences Inc stock is traded at $10.18, with a volume of 369,595. It is down -4.14% in the last 24 hours and up +18.10% over the past month. Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.
Previous Close:
$10.62
Open:
$10.41
24h Volume:
369,595
Relative Volume:
0.88
Market Cap:
$565.79M
Revenue:
$79.55M
Net Income/Loss:
-$37.25M
P/E Ratio:
-
EPS:
-$0.7054
Net Cash Flow:
-$25.40M
1W Performance:
-6.00%
1M Performance:
+18.10%
6M Performance:
+109.47%
1Y Performance:
+53.31%
1-Day Range:
$9.97$10.84
1-Week Range:
$9.97$10.95
52-Week Range:
$3.38$11.60
Sight Sciences Inc Stock (SGHT) Company Profile
Name
Sight Sciences IncSector
HealthcareIndustry
Medical DevicesPhone
(415) 889-0550Address
4040 CAMPBELL AVE,, MENLO PARK, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS